Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
暂无分享,去创建一个
R. Franchis | S. Saibeni | M. Vecchi | R. de Franchis | C. Folli | G. Borsi
[1] P. Rutgeerts,et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. , 2003, Gastroenterology.
[2] H. Hooijkaas,et al. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods , 2002, European journal of gastroenterology & hepatology.
[3] M. Abreu. Serologic tests are helpful in managing inflammatory bowel disease , 2002 .
[4] Y. Shoenfeld,et al. Serological markers in inflammatory bowel disease: the pros and cons , 2002, European journal of gastroenterology & hepatology.
[5] A. Šedivá,et al. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. , 2002, Clinical immunology.
[6] M. Daperno,et al. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[7] A. Zinsmeister,et al. Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease , 2001, Inflammatory bowel diseases.
[8] P. Rutgeerts,et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.
[9] S. Targan,et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. , 2001 .
[10] P. Rutgeerts,et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. , 2001, Gastroenterology.
[11] A. Maniatis,et al. Anti–saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease , 2001, American Journal of Gastroenterology.
[12] S. Targan,et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.
[13] D. Jewell,et al. A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.
[14] Roozendaal,et al. Are anti‐neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? , 1999, Clinical and experimental immunology.
[15] W. Sandborn,et al. Is antibody testing for inflammatory bowel disease clinically useful? , 1999, Gastroenterology.
[16] P. Banks,et al. The Role of pANCA and ASCA in Differentiating Ulcerative Colitis, Crohnʼs Disease, and Indeterminate Colitis , 1999 .
[17] S. Targan. The utility of ANCA and ASCA in inflammatory bowel disease. , 1999, Inflammatory bowel diseases.
[18] R. Macdermott. Lack of current clinical value of serological testing in the evaluation of patients with IBD. , 1999, Inflammatory bowel diseases.
[19] S. Targan,et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.
[20] P. Rutgeerts,et al. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. , 1998, Gastroenterology.
[21] G. Radford-Smith,et al. The significance of pANCA in inflammatory bowel disease , 1998, Journal of gastroenterology and hepatology.
[22] O. Goulet,et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn’s disease , 1998 .
[23] S. Targan,et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.
[24] P. Nos,et al. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease]. , 1998, Gastroenterologia y hepatologia.
[25] G. Ferry. The use of antineutrophil cytoplasmic antibodies to determine clinical patterns of ulcerative colitis in children. , 1998, Journal of pediatric gastroenterology and nutrition.
[26] A. Andriulli,et al. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. , 1998, Italian journal of gastroenterology and hepatology.
[27] P. Gionchetti,et al. Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. , 1997, Gut.
[28] S. Targan,et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. , 1996, Gastroenterology.
[29] S. Targan,et al. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. , 1996, Mayo Clinic proceedings.
[30] M. Astegiano,et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? , 1995, European journal of gastroenterology & hepatology.
[31] C. Florén,et al. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. , 1995, European journal of gastroenterology & hepatology.
[32] S. Targan,et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. , 1995, The American journal of gastroenterology.
[33] P. Gionchetti,et al. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis , 1994, The Lancet.
[34] L. Forzenigo,et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. , 1994, Digestion.
[35] C. Holdsworth,et al. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. , 1992, Gut.
[36] E. Lindberg,et al. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. , 1992, Gut.
[37] F. Seibold,et al. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.
[38] J. Colombel,et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. , 1992, Gastroenterologie clinique et biologique.
[39] S. Targan,et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.
[40] S. Allan,et al. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? , 1990, International archives of allergy and applied immunology.
[41] M. Kerr,et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.
[42] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[43] Truelove Sc,et al. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. , 1954 .
[44] S. Truelove,et al. Cortisone in Ulcerative Colitis , 1954 .